| scholarly article | Q13442814 |
| P50 | author | Roland Martin | Q69171707 |
| P2093 | author name string | Clemencia Pinilla | |
| Karen Yao | |||
| Naoko Ito | |||
| Henry F McFarland | |||
| Mark Bryant | |||
| Jacqueline A Quandt | |||
| Jaebong Huh | |||
| Kazuyuki Kawamura | |||
| Kouichi Ito | |||
| Mirza Baig | |||
| P2860 | cites work | Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans | Q24533132 |
| Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins | Q27628195 | ||
| A functional and structural basis for TCR cross-reactivity in multiple sclerosis | Q27639679 | ||
| Risk alleles for multiple sclerosis identified by a genomewide study | Q29614890 | ||
| Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency | Q30651294 | ||
| Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries | Q31041726 | ||
| Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. | Q33842739 | ||
| TCR affinity for self-ligands influences the development and function of encephalitogenic T cells | Q33855716 | ||
| A direct estimate of the human alphabeta T cell receptor diversity | Q33878476 | ||
| Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients | Q33890993 | ||
| Multiple sclerosis, vitamin D, and HLA-DRB1*15. | Q33899907 | ||
| HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course | Q33904555 | ||
| Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule | Q33947114 | ||
| Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. | Q34032006 | ||
| Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis | Q34095225 | ||
| Human T-cell response to myelin basic protein peptide (83-99): extensive heterogeneity in antigen recognition, function, and phenotype | Q73809910 | ||
| Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology | Q74477147 | ||
| Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group | Q74785782 | ||
| Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis | Q81390152 | ||
| Regulatory T cells in spontaneous autoimmune encephalomyelitis | Q34448458 | ||
| Functional epistasis on a common MHC haplotype associated with multiple sclerosis | Q34571353 | ||
| Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis | Q34657157 | ||
| RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. | Q34660473 | ||
| Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis | Q35137159 | ||
| Mice lacking all conventional MHC class II genes | Q35620743 | ||
| Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor | Q36152482 | ||
| A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis | Q36229747 | ||
| Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex | Q36368410 | ||
| Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice | Q36399873 | ||
| Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice | Q37297916 | ||
| HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis | Q38357177 | ||
| T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells | Q38502564 | ||
| HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. | Q40395752 | ||
| Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides | Q41022419 | ||
| The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele | Q41287692 | ||
| Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106 | Q41637939 | ||
| Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals | Q41717333 | ||
| HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals | Q41717464 | ||
| Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation | Q41889460 | ||
| Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones | Q42011739 | ||
| Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. | Q43197058 | ||
| Influence of a dominant cryptic epitope on autoimmune T cell tolerance | Q43867718 | ||
| Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals | Q44894889 | ||
| Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species | Q46193929 | ||
| Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes | Q47238652 | ||
| Proteolytic activity associated with purified myelin basic protein | Q48693905 | ||
| HL-A antigens and multiple sclerosis. | Q53892212 | ||
| Vitamin D and multiple sclerosis | Q54073705 | ||
| Genetics of multiple sclerosis | Q54114782 | ||
| Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis | Q56681076 | ||
| High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model | Q57704203 | ||
| The familial nature of multiple sclerosis: Age-corrected empiric recurrence risks for children and siblings of patients | Q68352996 | ||
| Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules | Q69088309 | ||
| HL-A antigens and multiple sclerosis | Q69420077 | ||
| Multiple Sclerosis: Association with HL—A3 | Q70493174 | ||
| High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice | Q71641038 | ||
| Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99) | Q71785371 | ||
| Cassette vectors directing expression of T cell receptor genes in transgenic mice | Q72150243 | ||
| CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection | Q72658265 | ||
| Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis | Q73128646 | ||
| Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis | Q73144676 | ||
| Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells | Q73224651 | ||
| A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor | Q73300264 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2897-2908 | |
| P577 | publication date | 2012-08-10 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis | |
| P478 | volume | 189 |
| Q30723942 | A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data? |
| Q92840146 | Association of human leukocyte antigen-DRB haplotype in multiple sclerosis population of Khuzestan, Iran |
| Q38911206 | Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis |
| Q38851770 | DNA Methylation: a New Player in Multiple Sclerosis |
| Q88438439 | Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis |
| Q35181321 | Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE. |
| Q50114920 | Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS). |
| Q50097667 | Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood. |
| Q38144104 | Immune response in chronic obstructive pulmonary disease |
| Q92286167 | Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15 |
| Q39350409 | Modulating inflammation and neuroprotection in multiple sclerosis |
| Q90049708 | Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis |
| Q46412279 | Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models |
| Q91277140 | Species differences in immune-mediated CNS tissue injury and repair: A (neuro)inflammatory topic |
| Q38050478 | Structural basis for self-recognition by autoimmune T-cell receptors. |
| Q88210748 | T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates |
| Q37505364 | Tolerogenic vaccines for Multiple sclerosis |
Search more.